AXSM insider transaction filings
Axsome Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen AXSM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 45,004 @ $4.95 · Sale (S): 45,004 @ $212.01 · Option exercise (M): 4,660 @ $4.95 · Sale (S): 4,660 @ $213.95 · Option exercise (M): 45,004 (derivative) @ $0 · Option exercise (M): 4,660 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 49,666 @ $4.95 · Sale (S): 49,666 @ $240.25 · Option exercise (M): 49,666 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | JEFFS ROGER — Director | Sale (S): 286 @ $246.18 · Sale (S): 286 @ $249.12 | EDGAR |
| 2026-06-10 | 4 | Coleman Mark — Director | Option exercise (M): 1,429 · Sale (S): 643 @ $249 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Mahony Susan — Director | Option exercise (M): 1,429 · Sale (S): 300 @ $237.21 · Sale (S): 300 @ $246.18 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Saad Mark E — Director | Option exercise (M): 1,429 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | JEFFS ROGER — Director | Option exercise (M): 1,429 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Coleman Mark — Director | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Pizzie Nick — Chief Financial Officer | Option exercise (M): 33,000 @ $3.50 · Sale (S): 33,000 @ $240.09 · Option exercise (M): 33,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Mahony Susan — Director | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Saad Mark E — Director | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | JEFFS ROGER — Director | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 49,670 @ $4.95 · Sale (S): 49,670 @ $241.01 · Option exercise (M): 49,670 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Coleman Mark — Director | Sale (S): 6,000 @ $233.46 · Sale (S): 6,000 @ $230.30 · Sale (S): 5,537 @ $223.39 | EDGAR |
| 2026-05-05 | 4 | Jacobson Mark L. — Chief Operating Officer | Option exercise (M): 4,517 @ $12.95 · Sale (S): 4,517 @ $227.94 · Option exercise (M): 233 @ $12.95 · Sale (S): 233 @ $228.18 · Option exercise (M): 4,517 (derivative) @ $0 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Jacobson Mark L. — Chief Operating Officer | Grant/award (A): 8,669 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Maizel Ari — Chief Commercial Officer | Option exercise (M): 7,500 @ $70.73 · Sale (S): 7,500 @ $182.42 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Maizel Ari — Chief Commercial Officer | Grant/award (A): 7,224 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Pizzie Nick — Chief Financial Officer | Grant/award (A): 8,188 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Murdock Hunter R. — General Counsel | Grant/award (A): 7,224 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Grant/award (A): 24,081 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Pizzie Nick — Chief Financial Officer | Grant/award (A): 18,570 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Murdock Hunter R. — General Counsel | Grant/award (A): 16,385 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Maizel Ari — Chief Commercial Officer | Grant/award (A): 16,385 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Jacobson Mark L. — Chief Operating Officer | Grant/award (A): 19,663 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Coleman Mark — Director | Sale (S): 25,000 @ $161.11 | EDGAR |
| 2026-02-27 | 4 | Jacobson Mark L. — Chief Operating Officer | Option exercise (M): 35,378 @ $2.85 · Sale (S): 35,378 @ $161.88 · Option exercise (M): 35,378 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Grant/award (A): 54,623 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Coleman Mark — Director | Option exercise (M): 6,250 @ $4.95 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Coleman Mark — Director | Option exercise (M): 12,485 @ $4.95 · Option exercise (M): 12,485 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Coleman Mark — Director | Option exercise (M): 5,193 @ $8.02 · Option exercise (M): 5,193 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 32,410 @ $8.02 · Sale (S): 32,410 @ $185.60 · Option exercise (M): 32,410 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Pizzie Nick — Chief Financial Officer | Option exercise (M): 12,000 @ $3.50 · Sale (S): 12,000 @ $187.92 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Maizel Ari — Chief Commercial Officer | Option exercise (M): 7,500 @ $70.73 · Sale (S): 7,500 @ $184.44 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 78,703 @ $8.02 · Sale (S): 78,703 @ $171.28 · Option exercise (M): 29,450 @ $8.02 · Sale (S): 29,450 @ $172.33 · Option exercise (M): 31,261 @ $8.02 · Sale (S): 31,261 @ $170.38 · +3 more | EDGAR |
| 2026-01-02 | 4 | Saad Mark E — Director | Option exercise (M): 6,231 @ $8.02 · Sale (S): 6,231 @ $165.18 · Option exercise (M): 31,346 @ $4.95 · Sale (S): 31,346 @ $165.18 · Option exercise (M): 6,231 (derivative) @ $0 · Option exercise (M): 31,346 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 49,252 @ $8.02 · Sale (S): 49,252 @ $144.59 · Option exercise (M): 20,163 @ $8.02 · Sale (S): 20,163 @ $146.94 · Option exercise (M): 10,558 @ $8.02 · Sale (S): 10,558 @ $148.18 · +3 more | EDGAR |
| 2025-11-05 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 91,705 @ $8.02 · Sale (S): 91,705 @ $132.34 · Option exercise (M): 50,459 @ $8.02 · Sale (S): 50,459 @ $133.79 · Option exercise (M): 21,775 @ $8.02 · Sale (S): 21,775 @ $134.49 · +3 more | EDGAR |
| 2025-10-08 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 19,220 @ $8.02 · Sale (S): 19,220 @ $120.17 · Option exercise (M): 13,390 @ $8.02 · Sale (S): 13,390 @ $118.77 · Option exercise (M): 12,774 @ $8.02 · Sale (S): 12,774 @ $118.84 · +3 more | EDGAR |
| 2025-09-22 | 4 | Jacobson Mark L. — Chief Operating Officer | Option exercise (M): 10,000 @ $2.85 · Sale (S): 10,000 @ $115.96 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Jacobson Mark L. — Chief Operating Officer | Sale (S): 5,783 @ $116.19 · Option exercise (M): 25,000 @ $4.95 · Option exercise (M): 15,000 @ $4.85 · Sale (S): 40,000 @ $114.23 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | TABUTEAU HERRIOT — Chief Executive Officer, Director, 10% owner | Option exercise (M): 27,907 @ $8.02 · Sale (S): 27,907 @ $118.96 · Option exercise (M): 15,254 @ $8.02 · Sale (S): 15,254 @ $117.37 · Option exercise (M): 19,719 @ $8.02 · Sale (S): 19,719 @ $114.19 · +3 more | EDGAR |
| 2025-09-09 | 4 | Coleman Mark — Director | Purchase (P): 800 @ $127.20 · Purchase (P): 287 @ $127.30 · Purchase (P): 488 @ $127.40 | EDGAR |
| 2025-09-05 | 4 | Saad Mark E — Director | Option exercise (M): 9,127 @ $9 · Sale (S): 9,127 @ $125.07 · Option exercise (M): 9,127 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | JEFFS ROGER — Director | Sale (S): 13,464 @ $123.68 | EDGAR |
| 2025-08-29 | 4 | JEFFS ROGER — Director | Sale (S): 20,000 @ $122.30 · Sale (S): 20,000 @ $121.60 · Sale (S): 20,000 @ $121.27 | EDGAR |
| 2025-08-26 | 4 | JEFFS ROGER — Director | Sale (S): 16,694 @ $120.08 · Sale (S): 20,000 @ $120.03 | EDGAR |
| 2025-06-23 | 4 | Murdock Hunter R. — General Counsel | Option exercise (M): 7,500 @ $29.91 · Sale (S): 7,500 @ $102.47 · Option exercise (M): 6,014 @ $29.91 · Sale (S): 6,014 @ $100.12 · Option exercise (M): 7,500 (derivative) @ $0 · Option exercise (M): 6,014 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Murdock Hunter R. — General Counsel | Option exercise (M): 7,500 @ $29.91 · Sale (S): 7,500 @ $102.42 · Option exercise (M): 7,500 @ $29.91 · Sale (S): 7,500 @ $100.26 · Option exercise (M): 7,500 @ $29.91 · Sale (S): 7,500 @ $100.90 · +3 more | EDGAR |
| 2025-06-10 | 4 | Coleman Mark — Director | Grant/award (A): 3,166 (derivative) @ $0 · Grant/award (A): 1,429 (derivative) @ $0 | EDGAR |
Recent 8-K events — Axsome Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXSM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →